Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | and similar dates through November 2027

Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.

Summary: Supports research on innovative screening and therapies for fatal or disabling disorders identified through newborn screening, including high-priority genetic conditions.

Key Information: Clinical trials are optional; foreign and domestic applicants are eligible; Data Management and Sharing Plan required.